0
Department of Health and Human Services Awarded a Contract to CURIA GLOBAL INC for $39,500,000.00
Signed on
3/16/2018, 12:00 AM
CURIA GLOBAL INC Government Contract #HHSN271201800001I
CURIA GLOBAL INC was awarded a contract with the United States Government for $39,500,000.00. The contract was awarded by the agency office NATIONAL INSTITUTES OF HEALTH NIDA, which is a division with the National Institutes of Health within the Department of Health and Human Services.
Summary of Award
The US federal government awarded a contract to Curia Global Inc, a U.S.-owned business based in Albany, New York, for the "Medicinal Chemistry Support Program for Therapeutic Development." The contract, with a total obligation of $39,500,000, falls under the category of an Indefinite Delivery / Indefinite Quantity (IDV) contract.
The contract was signed on March 16, 2018, and is set to run until March 15, 2028. The contract is part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract falls under the Research and Development in the Physical, Engineering, and Life Sciences category, specifically focusing on Health R&D Services, Health Care Services, and Applied Research.
The contract was awarded through a negotiated proposal/quote process, with full and open competition. There were four offers received for the contract, and it was ultimately awarded to Curia Global Inc as a single award contract. The contract is a cost-plus fixed fee type of contract pricing.
Curia Global Inc is a subsidiary of UIC Parent Corporation and operates in the professional, scientific, and technical services sector. The company specializes in providing research and development services in the physical, engineering, and life sciences, excluding nanotechnology and biotechnology.
The contract does not involve any subcontracting plan, multi-year contract, or consolidated contract. It is not part of any national interest action and does not involve any fair opportunity limitations. The contract is not related to the Department of Defense (DOD) programs and does not involve any construction wage rate or labor standards.
Overall, the contract between the US federal government and Curia Global Inc for the Medicinal Chemistry Support Program for Therapeutic Development is a significant investment in research and development services aimed at advancing therapeutic development in the health sector. The contract is expected to contribute to the advancement of scientific knowledge and potentially lead to the development of new treatments and therapies.